BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24937655)

  • 1. Prognostic value of neuropeptide proenkephalin A in patients with severe traumatic brain injury.
    Gao JB; Tang WD; Wang X; Shen J
    Peptides; 2014 Aug; 58():42-6. PubMed ID: 24937655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of neuropeptide proenkephalin A predict outcome in patients with aneurysmal subarachnoid hemorrhage.
    Chen XL; Yu BJ; Chen MH
    Peptides; 2014 Jun; 56():111-5. PubMed ID: 24727154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide proenkephalin A is associated with in-hospital mortality in patients with acute intracerebral hemorrhage.
    Yang XG; An HL; Zhang JM
    Peptides; 2014 Aug; 58():47-51. PubMed ID: 24937654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma copeptin concentration and outcome after pediatric traumatic brain injury.
    Lin C; Wang N; Shen ZP; Zhao ZY
    Peptides; 2013 Apr; 42():43-7. PubMed ID: 23402790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of adrenomedullin in patients with traumatic brain injury: potential contribution to prognosis.
    Chen TJ; Fu QY; Wu WQ
    Peptides; 2014 Jun; 56():146-50. PubMed ID: 24747282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma 8-iso-prostaglandin F2α concentration in severe human traumatic brain injury.
    Yu GF; Jie YQ; Wu A; Huang Q; Dai WM; Fan XF
    Clin Chim Acta; 2013 Jun; 421():7-11. PubMed ID: 23466601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke.
    Doehner W; von Haehling S; Suhr J; Ebner N; Schuster A; Nagel E; Melms A; Wurster T; Stellos K; Gawaz M; Bigalke B
    J Am Coll Cardiol; 2012 Jul; 60(4):346-54. PubMed ID: 22813614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of copeptin: one-year outcome in patients with traumatic brain injury.
    Yu GF; Huang Q; Dai WM; Jie YQ; Fan XF; Wu A; Lv Y; Li YP; Yan XJ
    Peptides; 2012 Jan; 33(1):164-9. PubMed ID: 22138140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in plasma visfatin level after severe traumatic brain injury.
    Chen J; Weng JF; Hong WC; Luo LF; Yu W; Luo SD
    Peptides; 2012 Nov; 38(1):8-12. PubMed ID: 22960047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum ficolin-3 levels are associated with severity and poor outcome in traumatic brain injury.
    Pan JW; Gao XW; Jiang H; Li YF; Xiao F; Zhan RY
    J Neuroinflammation; 2015 Dec; 12():226. PubMed ID: 26627059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma adiponectin levels in patients with severe traumatic brain injury.
    Shen LJ; Yang SB; Lv QW; Zhang GH; Zhou J; Guo M; Huang HB; Li Z; Yang CS
    Clin Chim Acta; 2014 Jan; 427():37-41. PubMed ID: 24099881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copeptin is associated with mortality in patients with traumatic brain injury.
    Dong XQ; Huang M; Yang SB; Yu WH; Zhang ZY
    J Trauma; 2011 Nov; 71(5):1194-8. PubMed ID: 21502880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma visfatin, a possible prognostic marker in aneurysmal subarachnoid hemorrhage.
    Wang JX; Hou Y; Ruan SP; Wang J; Hu XM
    Peptides; 2013 Dec; 50():8-12. PubMed ID: 24120704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-100beta protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury.
    Spinella PC; Dominguez T; Drott HR; Huh J; McCormick L; Rajendra A; Argon J; McIntosh T; Helfaer M
    Crit Care Med; 2003 Mar; 31(3):939-45. PubMed ID: 12627009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased plasma gelsolin is associated with 1-year outcome in patients with traumatic brain injury.
    Jin Y; Li BY; Qiu LL; Ling YR; Bai ZQ
    J Crit Care; 2012 Oct; 27(5):527.e1-6. PubMed ID: 22386223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the performances of copeptin and multiple biomarkers in long-term prognosis of severe traumatic brain injury.
    Zhang ZY; Zhang LX; Dong XQ; Yu WH; Du Q; Yang DB; Shen YF; Wang H; Zhu Q; Che ZH; Liu QJ; Jiang L; Du YF
    Peptides; 2014 Oct; 60():13-7. PubMed ID: 25076464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing intracranial pressure monitoring guideline compliance and outcome after severe traumatic brain injury.
    Biersteker HA; Andriessen TM; Horn J; Franschman G; van der Naalt J; Hoedemaekers CW; Lingsma HF; Haitsma I; Vos PE
    Crit Care Med; 2012 Jun; 40(6):1914-22. PubMed ID: 22488001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical score of Glasgow Coma Scale for pediatric traumatic brain injury.
    Chung CY; Chen CL; Cheng PT; See LC; Tang SF; Wong AM
    Pediatr Neurol; 2006 May; 34(5):379-87. PubMed ID: 16647999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury.
    Wang KY; Yu GF; Zhang ZY; Huang Q; Dong XQ
    Clin Chim Acta; 2012 Nov; 413(21-22):1737-41. PubMed ID: 22789964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief episodes of intracranial hypertension and cerebral hypoperfusion are associated with poor functional outcome after severe traumatic brain injury.
    Stein DM; Hu PF; Brenner M; Sheth KN; Liu KH; Xiong W; Aarabi B; Scalea TM
    J Trauma; 2011 Aug; 71(2):364-73; discussion 373-4. PubMed ID: 21825940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.